Antimicrobial Stewardship Education Through Virtual Clinical Cases

Abstract

Antimicrobial stewardship (AMS) is a cornerstone of modern infectious disease management, aimed at optimizing antimicrobial use to combat resistance and improve patient outcomes. Traditional educational strategies for AMS have been challenged by limited resources and variable clinical exposure. Recent advances in medical education harness virtual clinical cases (VCCs) as interactive, scalable, and evidence-based tools for educating healthcare professionals. This review critically examines the impact of VCCs on AMS education, discusses their integration into clinical training, and evaluates their effectiveness through the lens of current research and guideline recommendations.

Introduction

The emergence of multidrug-resistant organisms and the global threat of antimicrobial resistance (AMR) have necessitated robust AMS programs. Education forms the foundation of AMS, equipping clinicians with the knowledge and skills required for judicious antimicrobial prescribing. However, conventional didactic formats often lack the interactivity and context-specific learning needed for effective behavior change. Virtual clinical cases offer a dynamic, case-based approach that simulates real-world scenarios, fostering clinical reasoning and practical decision-making. This article explores the scientific basis and practical implications of incorporating VCCs into AMS education for healthcare professionals.

Epidemiology / Disease Burden

AMR represents one of the most pressing global health challenges, with the World Health Organization (WHO) estimating over 700,000 annual deaths attributable to resistant infections. Inappropriate antimicrobial use is a recognized driver of resistance, with studies indicating that up to 50% of hospital antibiotic prescriptions may be unnecessary or suboptimal. The burden is particularly high in intensive care units, oncology wards, and long-term care settings, where vulnerable populations are at increased risk. The COVID-19 pandemic has further exacerbated inappropriate antibiotic use, underscoring the urgent need for effective AMS education and interventions.

Pathophysiology

AMR arises from the selective pressure exerted by antimicrobial agents on microbial populations, favoring the survival and proliferation of resistant strains. Mechanisms include enzymatic degradation of drugs (e.g., beta-lactamases), alteration of drug targets, efflux pumps, and biofilm formation. These mechanisms can be intrinsic to the organism or acquired via horizontal gene transfer. The inappropriate use of broad-spectrum agents accelerates resistance, highlighting the importance of targeted therapy based on microbiological and pharmacodynamic principles. AMS education must therefore address the scientific underpinnings of resistance and the rationale for stewardship interventions.

Risk Factors

Key risk factors for AMR include excessive and prolonged antimicrobial use, empirical therapy without de-escalation, subtherapeutic dosing, and inadequate infection control practices. Patient-level factors such as immunosuppression, frequent hospitalizations, and invasive procedures further contribute to risk. Institutional factors, including formulary restrictions, prescriber habits, and local resistance patterns, also play a role. VCCs allow learners to explore these risk factors interactively, applying knowledge to diverse clinical contexts and reinforcing the importance of individualized care.

Clinical Features

Clinical manifestations of infections caused by resistant organisms are often indistinguishable from those due to susceptible strains, necessitating a high index of suspicion, especially in patients with known risk factors or treatment failure. Common presentations include persistent fever, worsening organ dysfunction, and lack of response to standard therapy. VCCs can simulate such scenarios, challenging learners to recognize potential resistance, interpret microbiological data, and adjust management accordingly.

Diagnosis

Accurate diagnosis is foundational to AMS, encompassing clinical assessment, judicious use of diagnostic tests, and interpretation of microbiological results. Rapid diagnostic technologies, such as polymerase chain reaction (PCR) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), have enhanced pathogen identification and susceptibility profiling. VCCs can incorporate evolving diagnostic modalities, teaching clinicians to integrate laboratory data with clinical judgment for timely and precise therapy.

Treatment & Management

Effective AMS hinges on selecting the appropriate antimicrobial agent, dose, route, and duration, tailored to the infection syndrome and patient characteristics. Principles include timely initiation of empiric therapy, early de-escalation based on culture results, and avoidance of unnecessary combinations. Non-pharmacologic interventions, such as source control and infection prevention, are equally vital. Through VCCs, learners can practice these principles in simulated environments, receiving immediate feedback and guidance on stewardship best practices.

Recent Advances / Emerging Therapies

Recent years have witnessed the development of novel antimicrobials targeting resistant pathogens, adjunctive therapies such as monoclonal antibodies, and the application of artificial intelligence in predicting resistance patterns. Digital health platforms now enable remote AMS rounds and tele-stewardship consultations. VCCs are uniquely positioned to integrate these advances into education, allowing clinicians to stay abreast of new therapies and evolving guidelines while honing decision-making skills in complex cases.

Guideline Recommendations

Leading organizations, including the Infectious Diseases Society of America (IDSA) and WHO, emphasize education as a core component of AMS programs. Guidelines advocate for interactive, case-based learning, multidisciplinary engagement, and the use of technology to enhance access and scalability. VCCs align with these recommendations by providing standardized, reproducible, and customizable learning experiences. Evidence supports their effectiveness in improving knowledge, attitudes, and prescribing behaviors among healthcare professionals.

Conclusion

Virtual clinical cases represent a transformative approach to AMS education, bridging the gap between theoretical knowledge and clinical application. By simulating real-world challenges, VCCs foster critical thinking, promote adherence to stewardship principles, and support the development of competent, confident prescribers. As the landscape of infectious diseases and AMR continues to evolve, the integration of VCCs into AMS curricula will be essential for safeguarding the efficacy of antimicrobials and optimizing patient care.